|
| ABT-639 Basic information |
Product Name: | ABT-639 | Synonyms: | ABT-639;4-Chloro-2-fluoro-N-(2-fluorophenyl)-5-[[(8aR)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]carbonyl]benzenesulfonamide;4-CHLORO-2-FLURO-N-(2-FLUOROPHENYL)-5-[(8AR)-HEXAHYDROPYRROLO[1,2-A]PYRAZIN-2(1H)-YLCARBONYL]BENZENESULFONAMIDE;ABT-639, CID 46851313;(R)-4-chloro-2-fluoro-N-(2-fluorophenyl)-5-(octahydropyrrolo[1,2-a]pyrazine-2-carbonyl)benzenesulfonamide;ABT-639 (ABT639;CS-2286;ABT-693 | CAS: | 1235560-28-7 | MF: | C20H20ClF2N3O3S | MW: | 455.91 | EINECS: | | Product Categories: | | Mol File: | 1235560-28-7.mol | ![ABT-639 Structure](CAS/20180808/GIF/1235560-28-7.gif) |
| ABT-639 Chemical Properties |
Boiling point | 612.2±65.0 °C(Predicted) | density | 1.51±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO:9.71(Max Conc. mg/mL);21.3(Max Conc. mM) DMF:14.0(Max Conc. mg/mL);30.71(Max Conc. mM) DMF:PBS (pH 7.2) (1:20):0.04(Max Conc. mg/mL);0.09(Max Conc. mM) Ethanol:0.5(Max Conc. mg/mL);1.1(Max Conc. mM) | form | A solid | pka | 6.80±0.10(Predicted) | color | White to off-white |
| ABT-639 Usage And Synthesis |
Description | ABT-639 is a T-type calcium channel blocker. It inhibits inactivated-state Cav3.2 channels with an IC50 value of 2.3 μM and inactivated-state Cav3.1 and Cav3.3 channels by 50 and 39%, respectively, when used at a concentration of 10 μM. ABT-639 selectively inhibits inactivated-state T-type calcium currents over resting-state currents in rat dorsal root ganglion (DRG) neurons (IC50s = 7.6 and >30 μM, respectively). It reverses the hind limb grip force deficit in a rat model of osteoarthritic pain induced by monoiodoacetic acid (MIA; ED50 = 2 mg/kg). ABT-639 also increases the paw withdrawal threshold in rat spinal nerve ligation (SNL) and chronic constriction injury (CCI) models of neuropathic pain in a dose-dependent manner and attenuates cold allodynia in the CCI rat model when administered at doses greater than or equal to 3 mg/kg. | Description | ABT-639 is a selective T-type calcium channel blocker with efficacy in a wide range of preclinical models of nociceptive and neuropathic pain.ABT-639 produces robust antinociceptive activity in experimental pain models at doses that do not significantly alter psychomotor or hemodynamic function in the rat. | storage | Store at -20°C | References | Zhang, Q., et al. "Optimization of ADME Properties for Sulfonamides Leading to the Discovery of a T-Type Calcium Channel Blocker, ABT-639."Acs Medicinal Chemistry Letters6.6(2015):150429091057009.
Serra, J, et al. "Effects of a T-type calcium channel blocker, ABT-639, on spontaneous activity in C-nociceptors in patients with painful diabetic neuropathy: a randomized controlled trial. " Pain 156.11(2015):2175.
http://www.medkoo.com/products/6989 |
| ABT-639 Preparation Products And Raw materials |
|